Entourage Effect:

  • Hanuš LO, Hod Y: Terpenes/Terpenoids in Cannabis: Are They Important? MCA 2020, 3(1) ↓ PDF

  • Santiago M et al: Absence of Entourage: Terpenoids Commonly Found In Cannabis sativa Do Not Modulate the Functional Activity of delta-9-THC at Human CB1 and CB2 Receptors. CCR 2019; 4(3) ↓ PDF

Pharmakokinetics:

  • Kocis PT, Vrana KE: Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. MCA 2020, 3(1) ↓ PDF
  • Meyer P. · Langos M. · Brenneisen R.: Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations. MCA 2018, 1(1) ↓ PDF
  • Millar SA et al: Towards Better Delivery of Cannabidiol (CBD). Pharmaceuticals 2020, 13: 219 ↓ PDF

 Dementia:

  • Broers B, Patà Z, Mina A, Wampfler J, de Saussure C, Pautex S: Prescription of a THC/CBD-Based Medication to Patients with Dementia: A Pilot Study in Geneva. MCA 2019, 2(1) ↓ PDF

Anxiety:

  • Wright M et al: Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. CCR 2020, 5(3) ↓ PDF

Sleep:

  • Walsh JH et al: Treating Insomnia Symptoms with Medicinal Cannabis: A Randomized, Cross-Over Trial of the Efficacy of a Cannabinoid Medicine Compared with Placebo. Sleep 2021 ↓ PDF

Gynecology:

  • Luschnig P, Schicho R: Cannabinoids in Gynecological Disease. MCA 2019, 2(1)  ↓ PDF

Tourette Syndrome:

  • Szejko N, Jakubovski E, Fremer C, Müller-Vahl KR: Vaporized Cannabis Is Effective and Well-Tolerated in an Adolescent with Tourette Syndrome. MCA 2019, 2(1) ↓ PDF
  • Müller-Vahl K: Case in Context: Tourette Syndrome. CCR March 2021 ↓ PDF

Epilepsy:

  • Zafar RR, Schlag AK, Nutt DJ: Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients. Drug Science, Policy and Law 2020; 6: 1-6 ↓ PDF

Pain:

  • Gazendam A et al: Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis. CCR 2020, 5(4) ↓ PDF
  • van Orten-Luiten ACB et al: Effects of Cannabidiol Chewing Gum on Perceived Painand Well-Being of Irritable Bowel Syndrome Patients:A Placebo-Controlled Crossover Exploratory InterventionStudy with Symptom-Driven Dosing. CCR 2021  ↓ PDF
  • Dunn KE et al: Within-subject, double-blinded, randomized, and placebocontrolled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model. Neuropsychopharmacology 2021 ↓ PDF
  • Zylla DM et al: A randomized trial of medical cannabis with patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction. Supp Care Cancer 2021 ↓ PDF

IBS:

  • van Orten-Luiten ACB et al: Effects of Cannabidiol Chewing Gum on Perceived Painand Well-Being of Irritable Bowel Syndrome Patients:A Placebo-Controlled Crossover Exploratory InterventionStudy with Symptom-Driven Dosing. CCR 2021  ↓ PDF

Placebo Effect:

  • Gertsch J.: The Intricate Influence of the Placebo Effect on Medical Cannabis and Cannabinoids. MCA 2018, 1(1) ↓ PDF

Analytics, QC:

  • Espel Grekopoulos J: Construction and Validation of Quantification Methods for Determining the Cannabidiol Content in Liquid Pharma-Grade Formulations by Means of Near-Infrared Spectroscopy and Partial Least Squares Regression. MCA 2019, 2(1) ↓ PDF
  • Hazekamp A.: The Trouble with CBD Oil. MCA 2018, 1(1) ↓ PDF

Botanics:

  • Jin D et al: Identification of phenotypic characteristics in three chemotype categories in the genus Cannabis. HortScience Febr 2021 ↓ PDF
  • Ren G et al: Large-scale whole-genome resequencing unravels the domestication histrory of Cannabis sativa. Sci Adv 2021, 7 ↓ PDF

Opioid Crisis:

  • Piomelli D: Cannabis and the opioid crisis. CCR 2018 ↓ PDF

Various Topics:

Handbooks:

  • Ahmad S, Hill KP: Medical Marijuana: A Clinical Handbook. Wolters Kluwer 2020